Related references
Note: Only part of the references are listed.A real world multicenter retrospective study on extramedullary disease from Balkan Myeloma Study Group and Barcelona University: analysis of parameters that improve outcome
Meral Beksac et al.
HAEMATOLOGICA (2020)
B cell maturation antigen-specific chimeric antigen receptor T cells for relapsed or refractory multiple myeloma: A meta-analysis
Nico Gagelmann et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2020)
Multiple myeloma with central nervous system relapse
Philip A. Egan et al.
HAEMATOLOGICA (2020)
Carfilzomib Based Treatment Strategies in the Management of Relapsed/Refractory Multiple Myeloma with Extramedullary Disease
Xiang Zhou et al.
CANCERS (2020)
Hematogenous extramedullary relapse in multiple myeloma - a multicenter retrospective study in 127 patients
Irit Avivi et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
Tandem Autologous Stem Cell Transplantation Improves Outcomes in Newly Diagnosed Multiple Myeloma with Extramedullary Disease and High-Risk Cytogenetics: A Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation
Nico Gagelmann et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Multiple myeloma with onset of pancreas involvement A case report
Xin Wang et al.
MEDICINE (2019)
Clinicopathological Profile of Myelomatous Pleural Effusion: Single-center Real-world Experience and Review of Literature
Uday Yanamandra et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2019)
Multiple myeloma with testicular involvement: A case report
Kaori Yamashita et al.
UROLOGY CASE REPORTS (2019)
Allogeneic stem-cell transplantation for multiple myeloma: a systematic review and meta-analysis from 2007 to 2017
Xuejiao Yin et al.
CANCER CELL INTERNATIONAL (2018)
Impact of extramedullary disease in patients with newly diagnosed multiple myeloma undergoing autologous stem cell transplantation: a study from the Chronic Malignancies Working Party of the EBMT
Nico Gagelmann et al.
HAEMATOLOGICA (2018)
Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European Expert Panel
J. Caers et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Impact of extramedullary disease in patients with newly diagnosed multiple myeloma undergoing autologous stem cell transplantation: a study from the Chronic Malignancies Working Party of the EBMT
Nico Gagelmann et al.
HAEMATOLOGICA (2018)
Double Vs Single Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma: Long-Term Follow-up (10-Years) Analysis of Randomized Phase 3 Studies
Michele Cavo et al.
BLOOD (2018)
Proptosis and hemiplegia as an initial manifestation of multiple myeloma
N. Tahiliani et al.
JOURNAL OF POSTGRADUATE MEDICINE (2018)
Efficacy of VDT PACE-like regimens in treatment of relapsed/refractory multiple myeloma
Arjun Lakshman et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
The possible role of burden of therapy on the risk of myeloma extramedullary spread
Silvia Mangiacavalli et al.
ANNALS OF HEMATOLOGY (2017)
Multiple myeloma with extramedullary disease: impact of autologous stem cell transplantation on outcome
L. Kumar et al.
BONE MARROW TRANSPLANTATION (2017)
Long non-coding RNA MALAT1 is an inducible stress response gene associated with extramedullary spread and poor prognosis of multiple myeloma
Hiroshi Handa et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
Multiple Myeloma Presenting as Thyroid Plasmacytoma
Kaalindi Singh et al.
INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY (2017)
Cytogenetics in multiple myeloma patients progressing into extramedullary disease
Lenka Besse et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2016)
Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma: Focus on Longitudinal Assessment of Donor Chimerism, Extramedullary Disease, and High-Risk Cytogenetic Features
Leo Rasche et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
Clinical efficacy of daratumumab monotherapy in patients with heavily pretreated relapsed or refractory multiple myeloma
Saad Z. Usmani et al.
BLOOD (2016)
Cutaneous involvement in multiple myeloma: a multi-institutional retrospective study of 53 patients
Artur Jurczyszyn et al.
LEUKEMIA & LYMPHOMA (2016)
Heparanase-induced shedding of syndecan-1/CD138 in myeloma and endothelial cells activates VEGFR2 and an invasive phenotype: prevention by novel synstatins
O. Jung et al.
ONCOGENESIS (2016)
Incidence and clinical features of extramedullary multiple myeloma in patients who underwent stem cell transplantation
Mathew Weinstock et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Development of extramedullary myeloma in the era of novel agents: no evidence of increased risk with lenalidomide-bortezomib combinations
Cindy Varga et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
The t(11;14)(q13;q32) Trans location as a Poor Prognostic Parameter for Autologous Stem Cell Transplantation in Myeloma Patients With Extramedullary Plasmacytoma
Ho-Jin Shin et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2015)
Features of Extramedullary Disease of Multiple Myeloma: High Frequency of P53 Deletion and Poor Survival: A Retrospective Single-Center Study of 834 Cases
Shuhui Deng et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2015)
NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma
Aaron P. Rapoport et al.
NATURE MEDICINE (2015)
Upregulation of lncRNA MEG3 Promotes Osteogenic Differentiation of Mesenchymal Stem Cells From Multiple Myeloma Patients By Targeting BMP4 Transcription
Wenzhuo Zhuang et al.
STEM CELLS (2015)
The lymphoma-like polychemotherapy regimen Dexa-BEAM in advanced and extramedullary multiple myeloma
Leo Rasche et al.
ANNALS OF HEMATOLOGY (2014)
Comparison of outcomes after autologous stem cell transplantation between myeloma patients with skeletal and soft tissue plasmacytoma
Ho-Jin Shin et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2014)
Soft-tissue extramedullary multiple myeloma prognosis is significantly worse in comparison to bone-related extramedullary relapse
Ludek Pour et al.
HAEMATOLOGICA (2014)
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
S. Vincent Rajkumar et al.
LANCET ONCOLOGY (2014)
Sinonasal extramedullary plasmacytoma: a systematic review of 175 patients
Christine D'Aguillo et al.
INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2014)
Cytogenetics of extramedullary manifestations in multiple myeloma
Lisa Billecke et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group
C. Fernandez de Larrea et al.
LEUKEMIA (2013)
Double Vs Single Autologous Stem Cell Transplantation After Bortezomib-Based Induction Regimens For Multiple Myeloma: An Integrated Analysis Of Patient-Level Data From Phase European III Studies
Michele Cavo et al.
BLOOD (2013)
Hypoxia promotes dissemination of multiple myeloma through acquisition of epithelial to mesenchymal transition-like features
Abdel Kareem Azab et al.
BLOOD (2012)
Extramedullary intracranial localization of multiple myeloma and treatment with novel agents: A retrospective survey of 50 patients
Alessandro Gozzetti et al.
CANCER (2012)
Extramedullary disease portends poor prognosis in multiple myeloma and is over-represented in high-risk disease even in the era of novel agents
Saad Z. Usmani et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Soft-Tissue Plasmacytomas in Multiple Myeloma: Incidence, Mechanisms of Extramedullary Spread, and Treatment Approach
Joan Blade et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Incidence of extramedullary disease in patients with multiple myeloma in the era of novel therapy, and the activity of pomalidomide on extramedullary myeloma
K. Detweiler Short et al.
LEUKEMIA (2011)
Incidence, presenting features and outcome of extramedullary disease in multiple myeloma: a longitudinal study on 1003 consecutive patients
M. Varettoni et al.
ANNALS OF ONCOLOGY (2010)
Characterization of Wnt/β-catenin signalling in osteoclasts in multiple myeloma
Ya-Wei Qiang et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Characteristics of Orbital Multiple Myeloma: A Case Report and Literature Review
Cat N. Burkat et al.
SURVEY OF OPHTHALMOLOGY (2009)
Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma
Yazan Alsayed et al.
BLOOD (2007)
Overexpression of tetraspanins affects multiple myeloma cell survival and invasive potential
Tali Tohami et al.
FASEB JOURNAL (2007)
Reduced-intensity conditioning allogeneic transplantation is associated with a high incidence of extramedullary relapses in multiple myeloma patients
JA Pérez-Simón et al.
LEUKEMIA (2006)
Extramedullary myeloma representing as a pericardial effusion with tamponade: Two case reports and a further review of 19 cases in the literature
W Abelman et al.
LEUKEMIA & LYMPHOMA (2005)
Primary extramedullary plasmacytoma and multiple myeloma: phenotypic differences revealed by immunohistochemical analysis
M Kremer et al.
JOURNAL OF PATHOLOGY (2005)
Differential expression of CD56 and CD44 in the evolution of extramedullary myeloma
IMS Dahl et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Extramedullary sites of involvement in hematologic malignancies - Case 3. Hemorrhagic gastric plasmacytoma as the primary presentation in multiple myeloma
CS Chim et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Clinical and pathologic findings in 52 consecutively autopsied cases with multiple myeloma
K Oshima et al.
AMERICAN JOURNAL OF HEMATOLOGY (2001)
Extramedullary relapse after allogeneic bone marrow transplantation for haematological malignancy
G Chong et al.
BONE MARROW TRANSPLANTATION (2000)
Share Paper
